Loading...

Overcoming Limitations Inherent in Sulfamidase to Improve Mucopolysaccharidosis IIIA Gene Therapy

Sulfamidase (SGSH) deficiency causes mucopolysaccharidosis type IIIA (MPS IIIA), a lysosomal storage disease (LSD) that affects the CNS. In earlier work in LSD mice and dog models, we exploited the utility of adeno-associated viruses (AAVs) to transduce brain ventricular lining cells (ependyma) for...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Mol Ther
Main Authors: Chen, Yonghong, Zheng, Shujuan, Tecedor, Luis, Davidson, Beverly L.
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Gene & Cell Therapy 2018
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6079371/
https://ncbi.nlm.nih.gov/pubmed/29503202
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2018.01.010
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!